Treating to target of minimal disease activity and normal function in polyarticular juvenile idiopathic arthritis with adalimumab: analysis from a phase 3 clinical trial
Crossref DOI link: https://doi.org/10.1186/1546-0096-12-S1-P9
Published Online: 2014-09-17
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ruperto, Nicola
Lovell, Daniel
Quartier, Pierre
Ravelli, Angelo
Karunaratne, Mahinda
Kalabic, Jasmina
Cardoso, Anabela
Martini, Alberto
Horneff, Gerd
Article History
First Online: 17 September 2014